Infectious Disease and Microbiology – Hansenula Species

Overview

Hansenula species are yeasts that only rarely cause human infection. When clinically significant disease occurs, it is usually opportunistic and is more likely in immunocompromised patients or those with other major underlying conditions.

Reported manifestations include fungemia, endocarditis, meningitis, and mediastinal lymphadenitis.

Important Species

The source lists:

• Hansenula anomala

• Hansenula polymorpha

The taxonomy of these yeasts has changed over time, and older Hansenula names may appear under different genera in modern classifications.

Taxonomic Considerations

An important historical reclassification is:

Hansenula anomala → commonly known as Wickerhamomyces anomalus

Older literature may also use the name:

Pichia anomala

Therefore, Hansenula anomala, Pichia anomala, and Wickerhamomyces anomalus may appear in literature describing the same or closely corresponding organism under different taxonomic systems.

Microbiologic Characteristics

Hansenula species are:

• Yeasts

• Uncommon causes of human disease

• Capable of causing opportunistic invasive fungal infection

They should be distinguished from the much more common pathogenic yeast Candida.

Epidemiology

Human infection is:

Rare

The supplied material appears to have the epidemiology and diagnostic headings transposed: culture and identification in biopsy specimens are diagnostic methods, whereas rarity describes the epidemiology.

Risk Factors

Invasive infection is particularly important in patients with:

• Immunosuppression

• Serious underlying disease

• Prolonged hospitalization

• Intravascular devices

As with other unusual yeasts, recovery from a normally sterile site should be evaluated carefully for evidence of genuine invasive disease.

Fungemia

One of the major reported manifestations is:

Fungemia

Bloodstream infection may occur in vulnerable hospitalized or immunocompromised patients.

Possible clinical findings include:

• Persistent fever

• Sepsis

• Positive blood cultures for yeast

• Evidence of an intravascular or disseminated source

Endocarditis

Hansenula species can rarely cause fungal endocarditis.

Endocarditis should be considered when fungemia is persistent or accompanied by:

• Cardiac valve abnormalities

• New or changing murmur

• Embolic manifestations

• Echocardiographic evidence of vegetation

Fungal endocarditis is a serious invasive manifestation.

Meningitis

Rare cases of meningitis have been associated with Hansenula species.

Diagnosis depends on compatible neurologic findings together with recovery or identification of the organism from appropriate clinical specimens.

Mediastinal Lymphadenitis

The source also describes:

Mediastinal lymphadenitis

This manifestation is reported particularly in immunocompromised patients.

Because mediastinal lymphadenopathy has many infectious and noninfectious causes, tissue sampling may be important for establishing the diagnosis.

Diagnosis

Diagnosis is based on:

Culture

and

Identification of the fungus in clinical biopsy specimens

The appropriate specimen depends on the clinical syndrome.

Blood Culture

For suspected fungemia:

Blood cultures

may demonstrate the yeast.

Repeated recovery from blood, particularly in a symptomatic high-risk patient, supports clinically significant bloodstream infection.

Tissue Biopsy

For localized or deep-seated disease, biopsy can provide:

• Histopathologic evidence of fungal infection

• Material for fungal culture

• Confirmation that an unusual yeast represents tissue-invasive disease rather than colonization

Treatment

The source lists:

Intravenous amphotericin B

as the principal treatment.

It may be administered:

With or without flucytosine

particularly for serious invasive disease.

Treatment Considerations

Because Hansenula infections are rare, clinical treatment data are relatively limited.

Management of serious infection should consider:

• Site of infection

• Severity of illness

• Species identification

• Antifungal susceptibility when available

• Immune status

• Presence of infected intravascular or prosthetic material

Source Control

When fungemia is associated with an intravascular catheter or other infected foreign material, appropriate source control may be important.

For complicated infections such as endocarditis, combined medical and procedural management may be required.

High-Yield Clinical Pattern

Immunocompromised or medically complex patient

• ●

Persistent fungemia

• ●

Unusual yeast isolated from blood

• ●

Possible endocarditis or disseminated disease

→ Consider Hansenula species, particularly organisms now classified as Wickerhamomyces

Exam Essentials

Genus: Hansenula

Type: Yeast

Important species: H. anomala, H. polymorpha

Frequency: Rare human infection

Important modern name: H. anomala → Wickerhamomyces anomalus

Alternative historical name: Pichia anomala

Major infection: Fungemia

Other invasive infections: Endocarditis, meningitis

Additional manifestation: Mediastinal lymphadenitis

Major host association: Immunocompromised patients

Diagnosis: Culture + identification in biopsy specimens

Treatment in source: IV amphotericin B ± flucytosine

Management principle: Consider antifungal susceptibility and source control in invasive disease

Key clinical pearl: Hansenula species are rare opportunistic yeasts that can produce fungemia and serious invasive disease in immunocompromised patients. Hansenula anomala is an older name for the organism now commonly called Wickerhamomyces anomalus, so recognizing the taxonomic change is important when interpreting older infectious-disease literature.